Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease - Biospectroscopie Translationnelle Access content directly
Journal Articles Frontiers in Immunology Year : 2023

Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease

Laurent Juillard
  • Function : Author
Thierry Lobbedez
  • Function : Author
Mathieu Legendre
  • Function : Author
François Vrtovsnik
  • Function : Author
Maïté Daroux
  • Function : Author

Abstract

Background and objectives Activation of the complement system is involved in the pathogenesis of anti-glomerular basement membrane (anti-GBM) disease. Glomerular deposits of complement 3 (C3) are often detected on kidney biopsies. The primary objective of this study was to analyze the prognostic value of the serum C3 level and the presence of C3 glomerular deposits in patients with anti-GBM disease. Methods We conducted a retrospective cohort study of 150 single-positive patients with anti-GBM disease diagnosed between 1997 and 2017. Patients were categorized according to the serum C3 level (forming a low C3 (C3<1.23 g/L) and a high C3 (C3≥1.23 g/L) groups) and positivity for C3 glomerular staining (forming the C3+ and C3- groups). The main outcomes were kidney survival and patient survival. Results Of the 150 patients included, 89 (65%) were men. The median [interquartile range (IQR)] age was 45 [26–64]. At diagnosis, kidney involvement was characterized by a median [IQR] peak serum creatinine (SCr) level of 578 [298–977] µmol/L, and 106 (71%) patients required dialysis. Patients in the low C3 group (72 patients) had more severe kidney disease at presentation, as characterized by higher prevalences of oligoanuria, peak SCr ≥500 µmol/L (69%, vs. 53% in the high C3 group; p=0.03), nephrotic syndrome (42%, vs. 24%, respectively; p=0.02) and fibrous forms on the kidney biopsy (21%, vs. 8%, respectively; p=0.04). Similarly, we observed a negative association between the presence of C3 glomerular deposits (in 52 (41%) patients) and the prevalence of cellular forms (83%, vs. 58% in the C3- group; p=0.003) and acute tubulo-interstitial lesions (60%, vs. 36% in the C3- group; p=0.007). When considering patients not on dialysis at diagnosis, the kidney survival rate at 12 months was poorer in the C3+ group (50% [25-76], vs. 91% [78-100] in the C3- group; p=0.01), with a hazard ratio [95% confidence interval] of 5.71 [1.13-28.85] (p=0.04, after adjusting for SCr). Conclusion In patients with anti-GBM disease, a low serum C3 level and the presence of C3 glomerular deposits were associated with more severe disease and histological kidney involvement at diagnosis. In patients not on dialysis at diagnosis, the presence of C3 deposits was associated with worse kidney survival.
Fichier principal
Vignette du fichier
fimmu-14-1190394.pdf (1.14 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive

Dates and versions

hal-04172599 , version 1 (24-05-2024)

Identifiers

Cite

Pauline Caillard, Cécile Vigneau, Jean-Michel Halimi, Marc Hazzan, Eric Thervet, et al.. Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease. Frontiers in Immunology, 2023, 14, ⟨10.3389/fimmu.2023.1190394⟩. ⟨hal-04172599⟩
57 View
3 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More